Michael Cecchini

机构：Yale New Haven Hospital, University of Toronto, York University, York Central Hospital, Women's College Hospital, Yale Cancer Center, Yale University · ORCID：0000-0003-3504-0128

发表论文 285 篇 · 总被引 1255 次 · h-index 16

代表论文

• A comparative mutation–selection reanalysis of colon and rectal adenocarcinoma highlights PIK3CA variants and BRAF V600E (2026 · Journal of Translational Medicine)
• B-cell/plasma cell gene co-expression modules enriched in Hidradenitis Suppurativa lesions and tunnels (2026 · Journal of Investigative Dermatology)
• Supplementary Table S3 from The Randomized Phase II ARC-9 Study of Etrumadenant-Based Therapy versus Regorafenib in Patients with Previously Treated Metastatic Colorectal Cancer (2026)
• Supplementary Table S1 from The Randomized Phase II ARC-9 Study of Etrumadenant-Based Therapy versus Regorafenib in Patients with Previously Treated Metastatic Colorectal Cancer (2026)
• Data from The Randomized Phase II ARC-9 Study of Etrumadenant-Based Therapy versus Regorafenib in Patients with Previously Treated Metastatic Colorectal Cancer (2026)
• Supplementary Figure S2 from The Randomized Phase II ARC-9 Study of Etrumadenant-Based Therapy versus Regorafenib in Patients with Previously Treated Metastatic Colorectal Cancer (2026)